Large-scale testing (Phase 3)Not Yet RecruitingNCT07776873
What this trial is testing
Intravenous Recombinant Human Prourokinase for Acute Medium Vessel Occlusion 4.5-24 Hours After Ischemic Stroke
Who this might be right for
Acute Ischemic Stroke
The First Affiliated Hospital of Anhui Medical University 616